Patents by Inventor Emily MARSHALL
Emily MARSHALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240130326Abstract: The present disclosure relates to a kit comprising: (i) a first part comprising a food bowl assembly including a first bowl having side walls and a base; a second feeding bowl disposed within the first bowl, the second feeding bowl having side walls and a solid base, the inner surface of said side walls and solid base being a closed surface; a separating module adapted to hold an olfactive product, the separating module being arranged to fit between the solid base of the second feeding bowl and the first bowl, and a vent arranged to allow odours from the separating module to exit the food bowl assembly between the first bowl and the side walls of the second feeding bowl so that odours do not pass through the second feeding bowl; and (ii) a second part comprising of a container comprising at least one olfactive product.Type: ApplicationFiled: October 29, 2020Publication date: April 25, 2024Applicant: MARS, INCORPORATEDInventors: Annabelle Goyon, Sandrine Vialle, Melanie Trehiou, Mathieu Mao, Tammie King, Alysia Hunt, Emily Marshall, Lewis Jones
-
Publication number: 20240046394Abstract: A method and system for accelerating employee growth is disclosed. A growth track is created. The growth track is associated with one or more competencies. The growth track is associated with one or more track levels. The growth track is aligned with a job architecture. The job architecture includes a job function, a job type, and one or more job tracks. The one or more job levels are mapped to the one or more track levels. A growth area is created. The growth area relates to one or more competencies. A user interface is caused to be presented on a device of a user based on the user being associated with the job function and the job type. The user interface allows the user to share an update pertaining to a progress of the user within the growth area.Type: ApplicationFiled: July 28, 2023Publication date: February 8, 2024Inventors: Aleksandr Mistratov, Srilakshmi Manikantan, Joan Roig Arderiu, Jared Erondu, Ricky Rizal Zein, Teresa Do, Chuen Yan Lau, Scott Dennis Lindley, Neil Phillip Steiner, Angeles Arena, Sergio Minutoli, Colin VanLang, Benjamin Ki, Hari Vignesh Ganesan, Samuel John Brian Coxon, Sarah Zhao, Harmony Merva Geauvreau-Dashut, Thomas Chang, Jeffrey Cheung, Emily Marshall, Adam Romel David, Lance Allen Laughlin, JR., Carrie Jo Noonan, Nayana Srivastava, Jaclyn Anh Tu Tran, Kevin Cook, Dina Deng, Audrey Chou, Jay Ashish Mahabal
-
Patent number: 11628215Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: GrantFiled: August 31, 2020Date of Patent: April 18, 2023Assignees: Vir Biotechnology, Inc., Triad National Security, LLC, Oregon Health & Science UniversityInventors: Eric Bruening, Klaus Frueh, Louis Picker, Bette T. M. Korber, James Theiler, Emily Marshall
-
Patent number: 11554168Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: GrantFiled: August 31, 2020Date of Patent: January 17, 2023Assignees: Vir Biotechnology, Inc., Triad National Security, LLC, Oregon Health & Science UniversityInventors: Eric Bruening, Klaus Frueh, Louis Picker, Bette T. M. Korber, James Theiler, Emily Marshall
-
Publication number: 20220288195Abstract: The present disclosure relates to isolated polynucleotides and polypeptides, and related hepatitis B virus (HBV)vaccines. The present disclosure also relates to viral vectors for expressing such polypeptides, and which may be used in HBV vaccines, as well as methods of protecting a subject from HBV infection and methods of treating HBV in a subject comprising administering the polypeptides, vectors, or vaccines described herein. Methods of designing and producing an HBV vaccine comprising designing vaccine antigens to cover the diversity within a geographic area using an antigen amino acid sequence that efficiently covers the epitopes in the HBV genotypes present in the geographic area are also provided herein.Type: ApplicationFiled: August 28, 2020Publication date: September 15, 2022Inventors: Eric BRUENING, Janet DOUGLAS, Emily MARSHALL, Karina YUSIM, Bette KORBER, James THEILER
-
Publication number: 20210106028Abstract: A pet food product comprising a fat component in an amount of from 2.0 wt % to 8.0 wt % by total weight of the pet food product, and a proteinaceous component in an amount of from 6.0 wt % to 14.0 wt % by total weight of the pet food product, wherein said proteinaceous component comprises polypeptides and free amino acids, wherein the ratio of the fat component to the proteinaceous component is from about 0.45:1.0 to about .0:1.0, and wherein the amount of free amino acids in the pet food product is at least 0.5 wt % by total weight of the pet food product.Type: ApplicationFiled: December 20, 2018Publication date: April 15, 2021Applicant: MARS, INCORPORATEDInventors: Scott MCGRANE, James W. MARSHALL, Alice DEAL, Emily MARSHALL
-
Publication number: 20210046174Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: ApplicationFiled: August 31, 2020Publication date: February 18, 2021Inventors: Eric Bruening, Klaus Frueh, Louis Picker, Bette T.M. Korber, James Theiler, Emily Marshall
-
Publication number: 20210046175Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: ApplicationFiled: August 31, 2020Publication date: February 18, 2021Inventors: Eric Bruening, Klaus Frueh, Louis Picker, Bette T.M. Korber, James Theiler, Emily Marshall
-
Patent number: 10894078Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: GrantFiled: October 5, 2015Date of Patent: January 19, 2021Assignees: Vir Biotechnology, Inc., Triad National Security, LLC, Oregon Health & Science UniversityInventors: Eric Bruening, Klaus Frueh, Louis Picker, Bette T. M. Korber, James Theiler, Emily Marshall
-
Publication number: 20170319679Abstract: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.Type: ApplicationFiled: October 5, 2015Publication date: November 9, 2017Applicant: Vir Biotechnology, Inc.Inventors: Eric E. BRUENING, Klaus FRUEH, Louis PICKER, Bette T. KORBER, James THEILER, Emily MARSHALL